|
Terminal complement inhibition and control of hemolysis in patients with paroxysmal nocturnal hemoglobinuria who switched from high-dose eculizumab to ravulizumab: a phase IV, single-arm clinical trial |
Nov 2024 |
Haematologica |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
|
Targeted therapies for myelodysplastic syndromes/neoplasms (MDS): current landscape and future directions |
Nov 2024 |
Expert Review of Anticancer Therapy |
Myelodysplastic Syndromes (MDS) |
|
Supportive care strategies in myelodysplastic syndromes and acute myeloid leukemia in older adults: a national survey of Canadian hematologists |
Nov 2024 |
Annals of Hematology |
Myelodysplastic Syndromes (MDS) |
|
Real-world impact of luspatercept on red blood cell transfusions among patients with myelodysplastic syndromes: A United States healthcare claims database study |
Nov 2024 |
Leukemia Research |
Myelodysplastic Syndromes (MDS) |
|
Clinical and neurophysiological aspects of peripheral neuropathy in patients with myelodysplastic syndromes |
Nov 2024 |
British Journal of Haematology |
Myelodysplastic Syndromes (MDS) |
|
Sustained benefits of imetelstat on patient-reported fatigue in patients with lower-risk myelodysplastic syndromes ineligible for, or relapsed/refractory to, erythropoiesis-stimulating agents and high transfusion burden in the phase 3 IMerge study |
Nov 2024 |
Leukemia & Lymphoma |
Myelodysplastic Syndromes (MDS) |
|
Consensus recommendations for severe aplastic anemia |
Nov 2024 |
Blood Advances |
Aplastic Anemia |
|
Thrombosis in Paroxysmal Nocturnal Hemoglobinuria (PNH): From Pathogenesis to Treatment |
Nov 2024 |
International Journal of Molecular Sciences |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
|
Safety and efficacy of danicopan in patients with paroxysmal nocturnal hemoglobinuria: a systematic review and meta-analysis |
Oct 2024 |
Expert Review of Hematology |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
|
Future directions in myelodysplastic syndromes/neoplasms and acute myeloid leukaemia classification: from blast counts to biology |
Oct 2024 |
Histopathology |
Myelodysplastic Syndromes (MDS) |
